GSK has completed its first stages of clinical research on an injection that could replace the daily pill currently being used to prevent HIV infection and to treat HIV positive carriers.
Local authorities fill vacuum: Two heads of settlements share crisis management & aid details on ‘Black Saturday,’ stressing citizen participation's pivotal role in Israel's October 7 wake-up call.
"The AIDS epidemic is still with us," said Prof. Itzchak Levy, director of the HIV/AIDS center at Sheba Medical Center.
Grief on the scale of the fall of Jerusalem ultimately requires a vessel that both honors and contains it.
Specific monoclonal antibodies suppressed the virus for months after the AIDS ‘cocktail’ of drugs was stopped.
They will go on public display for the first time in the month-long exhibition at Sotheby's, which will then auction many of the items in September.
The study suggests that restoring and improving gut health could be the key to slowing HIV progression to AIDS.
Researchers in the UNC School of Medicine conclude that specialized immune cells in the brain can harbor latent, but replication-capable HIV.